首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
【24h】

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets

机译:骆驼单域抗体:用于细胞外和细胞内脑靶标体内成像的多功能工具

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Detection of intracerebral targets with imaging probes is challenging due to the non-permissive nature of blood-brain barrier (BBB). The present work describes two novel single-domain antibodies (VHHs or nanobodies) that specifically recognize extracellular amyloid deposits and intracellular tau neurofibrillary tangles, the two core lesions of Alzheimer's disease (AD). Following intravenous administration in transgenic mouse models of AD, in vivo real-time two-photon microscopy showed gradual extravasation of the VHHs across the BBB, diffusion in the parenchyma and labeling of amyloid deposits and neurofibrillary tangles. Our results demonstrate that VHHs can be used as specific BBB-permeable probes for both extracellular and intracellular brain targets and suggest new avenues for therapeutic and diagnostic applications in neurology. (C) 2016 Elsevier B.V. All rights reserved.
机译:由于血脑屏障(BBB)的非许可性质,使用成像探针检测脑内目标具有挑战性。本工作描述了两种新颖的单域抗体(VHH或纳米抗体),它们特异性识别细胞外淀粉样蛋白沉积物和细胞内tau神经原纤维缠结,这是阿尔茨海默氏病(AD)的两个核心病变。在AD转基因小鼠模型中静脉内给药后,体内实时双光子显微镜检查显示VHHs逐渐渗出BBB,在实质内扩散,并标记淀粉样沉积物和神经原纤维缠结。我们的结果表明,VHHs可用作细胞外和细胞内脑靶的特异性BBB渗透性探针,并为神经学中的治疗和诊断应用提供了新途径。 (C)2016 Elsevier B.V.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号